A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury
Clicks: 149
ID: 112020
AbstractBackground. Liver injury is a common complication of first-line anti-tuberculosis therapy. N-acetylcysteine (NAC) is widely used in patients with parac
| Reference Key |
sclinicala
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Moosa, Muhammed S;Maartens, Gary;Gunter, Hannah;Allie, Shaazia;Chughlay, Mohamed F;Setshedi, Mashiko;Wasserman, Sean;Hickman, Nicole;Stewart, Annemie;Sonderup, Mark;Spearman, Catherine Wendy;Cohen, Karen; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.